Bendamustine-based first line therapy in chronic lymphocytic leukemia (CLL) in treatment routine: Interim results of the non-interventional study Be-CeLL1st.

Ruffert, K., Aldaoud, A., Klausmann, M., Bruch, H.-R., Hansen, R., Losem, C., Frank, M., Straßl, L., 2014.

Oncol Res Treat 37(suppl 5)(P194), 53–54. doi:10.1159/000368945

Studie: Be-Cell-1st; Indikation: Hämoblastosen; Jahr: 2014; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com